Delivery Order SPE2DR25D1017-SPE2DR26F9CDE
- Not listed
- The Defense Logistics Agency awarded a $15,899.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TUKYSA 150 mg tablets (60-count units) on July 28, 2025, with an ultimate completion date of August 18, 2025. This non-competitive, non-set-aside delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of TUKYSA 150 mg tablets (120-count units) valued at $15,756.32 under a firm fixed-price contract. This competitively awarded, non-set-aside delivery order is scheduled for completion by June 26, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of TUKYSA 150 mg tablets in a quantity of 120 units, with a contract ceiling value of $13,381.41 and firm fixed pricing. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of January 21, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a task order issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of TUKYSA 150 mg tablets (60-count units) with a ceiling value of $26,714.40 and a firm fixed price structure. The contract, which represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), carries an ultimate completion date of December 22, 2025. This award...
- The Defense Logistics Agency awarded a $16,604.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 120 tablets of TUKYSA 150 mg, a pharmaceutical product supporting military healthcare needs. This non-competitive delivery order, issued on November 3, 2025, with an ultimate completion date of November 25, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $12,674.74 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of TUKYSA 150 mg tablets (60-count units) with a completion date of October 1, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of TUKYSA 150 mg tablets (120-count units) under a firm fixed-price contract. The order, valued at $26,762.82 with completion targeted for January 13, 2026, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $15.9K delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of TUKYSA 150 mg tablets (60-count units) with a firm fixed price structure and an ultimate completion date of September 3, 2025. This competitive award carries no set-aside designation and will be performed at the company's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $40,071.60 for TUKYSA 150 mg tablets (60-count units) on December 4, 2025, with an ultimate completion date of December 26, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and performed at the awardee's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $47,268.96 for TUKYSA 150 mg tablets (120-count units) from the Defense Logistics Agency Medical Supply Chain. This competitive award, issued on July 25, 2025, with an ultimate completion date of August 15, 2025, carries firm fixed pricing and represents a non-set-aside delivery order. The contract is performed at the vendor's Conshohocken location...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9CDEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of TUKYSA 150 mg tablets (120-count units) with a contract ceiling value of $13,381.41. This is a firm fixed-price delivery order with an ultimate completion date of January 21, 2026, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The award carries no set-aside designation, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company serves as a major pharmaceutical distributor to federal medical procurement needs. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical (designated SPE2DX) running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. This delivery order for TUKYSA, a specialized oncology medication, exemplifies the company's role in supplying brand-name pharmaceuticals and medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA Troop Support is planning to establish multiple regional Pharmaceutical Prime Vendor Global Program Generation V contracts, positioning AmerisourceBergen among the key contractors supporting federal military and veteran healthcare logistics.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.4k | 12/28/25 |